AVS Funding & Investors
Ann Arbor, MI
AVS is an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease. It was founded in 2018 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at University of Michigan, and Robert Chisena, Ph.D., Chief Technical Off...Read more
avspulse.comTotal Amount Raised: $68,520,000
AVS Funding Rounds
Series B
$36,000,000
Series B
$8,800,000
Series B Investors
Biostar VenturesCUE Growth PartnersSeries B
$20,000,000
Series B Investors
Biostar VenturesSeries A
$1,240,000
Series A Investors
Biostar VenturesSeed
$1,240,000
Funding info provided by Diffbot.